Top Markets
#1 Islamic Coin Islamic Coin +151.55%
#2 Black Phoenix Black Phoenix +25.61%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.62%
#4 Fake World Assets Fake World Assets +16.15%
#5 Akedo Akedo +12.71%
#6 OpenEden OpenEden +12.39%
#7 clBTC clBTC +11.98%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.81%
#9 Pons Pons +11.07%
#10 TENDIES TENDIES +9.06%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Nirvana Life Sciences Inc. Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc.

NIRV
Rangering i aksjer #40099
Nirvana Life Sciences Inc. specializes in the scientific investigation and... Nirvana Life Sciences Inc. specializes in the scientific investigation and creation of therapeutic offerings derived from psychedelics. Additionally, the company is engaged in pioneering methods for the isolation and purification of psychoactive compounds, as well as advancing cultivation techniques to enable large-scale growth of the relevant biological material. The organization was founded in 2020 and maintains its principal office in Vancouver, Canada.
Aksjekurs
$0.05137558
Sist synkronisert: 2026-02-23
Markedsverdi
$247.78K
Endring (1 dag)
0.00%
Endring (1 år)
-11.29%
Land
CA
Handel Nirvana Life Sciences Inc. (NIRV)

Kategori

Healthcare
Inntekter for Nirvana Life Sciences Inc. (NIRV)
Inntekter i 2026 TTM: 0
Ifølge Nirvana Life Sciences Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Nirvana Life Sciences Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE